| Chapter |
Browser
|
Adobe
|
|
|
|
Introduction |
|
|
| |
|
Editor |
|
-----
|
| |
|
Forward |
|
-----
|
| |
|
Dedication |
|
-----
|
| |
|
Acknowledgements |
|
-----
|
| |
|
Contributing
Authors |
|
-----
|
| |
|
Abbreviations |
|
-----
|
I.
|
Epidemiology
And Natural History Of HIV Infection In Women |
|
|
| |
|
Introduction |
|
-----
|
| |
|
HIV
Transmission |
|
-----
|
| |
|
Natural
History and HIV Disease Progression |
|
-----
|
| |
|
Future
Issues |
|
-----
|
| |
|
References |
|
-----
|
| II. |
Approach
To The Patient |
|
|
| |
|
General
Guidelines |
|
-----
|
| |
|
Evaluation
of the HIV Infected Woman |
|
-----
|
| |
|
The
Chronic Care Model |
|
-----
|
| |
|
References |
|
-----
|
|
III. |
Prevention
Of HIV |
|
|
| |
|
Introduction |
|
-----
|
| |
|
Risk
Assessment for STI/HIV Infections |
|
-----
|
| |
|
HIV
Counseling and Testing |
|
-----
|
| |
|
Behavioral
Intervention Models |
|
-----
|
| |
|
Published
Behavioral Intervention Trials |
|
-----
|
| |
|
Practical
Aspects of Counseling Patients About Sexual Risk Reduction
|
|
-----
|
| |
|
Ethnic
and Gender Considerations in Risk Reduction and Counseling |
|
-----
|
| |
|
Sexually
Transmitted Infections and the Risk of HIV Infection |
|
-----
|
| |
|
Condoms
and Prevention of HIV Infection |
|
-----
|
| |
|
Other
Forms of Contraception and the Risk of HIV Infection |
|
-----
|
| |
|
New
Approaches to HIV and STI Prevention:
Microbicides, Vaccines, and Postexposure Prophylaxis |
|
-----
|
| |
|
Prevention
Messages for HIV-Infected Women |
|
-----
|
| |
|
Conclusions |
|
-----
|
| |
|
References |
|
-----
|
|
IV. |
Primary
Medical Care |
|
|
| |
|
Introduction |
|
-----
|
| |
|
Initial
Evaluation |
|
-----
|
| |
|
Laboratory
Testing |
|
-----
|
| |
|
Antiretroviral
Therapy |
|
-----
|
| |
|
Complications:
Opportunistic Diseases |
|
-----
|
| |
|
Algorithms
for Diagnosis and Management of Symptoms |
|
-----
|
| |
|
References |
|
-----
|
| V. |
Adherence
To HIV Therapies |
|
|
| |
|
Introduction |
|
-----
|
| |
|
The
Unforgiving Nature of HIV and the Medications to Treat It |
|
-----
|
| |
|
Predictors
of Adherence |
|
-----
|
| |
|
Adherence
in Special Populations |
|
-----
|
| |
|
Measuring
Adherence |
|
-----
|
| |
|
Improving
Adherence |
|
-----
|
| |
|
Conclusions |
|
-----
|
| |
|
References |
|
-----
|
| VI. |
Gynecologic
Problems |
|
|
| |
|
Introduction |
|
-----
|
| |
|
Abnormal
Uterine Bleeding/Amenorrhea |
|
-----
|
| |
|
Abnormal
Pap Smear |
|
-----
|
| |
|
Genital
Ulcers |
|
-----
|
| |
|
Vaginal
Discharge |
|
-----
|
| |
|
Pelvic/Abdominal
Pain |
|
-----
|
| |
|
Pelvic
Mass |
|
-----
|
| |
|
Urinary
Symptoms |
|
-----
|
| |
|
Genital
Warts |
|
-----
|
| |
|
Genital
Masses/Nodules |
|
-----
|
| |
|
Genital
Itching/Irritation |
|
-----
|
| |
|
Breast
Lump |
|
-----
|
| |
|
Menopause |
|
-----
|
| |
|
Health
Maintenance Issues |
|
-----
|
| |
|
Guidelines
for Gynecologic Referral |
|
-----
|
| |
|
References |
|
-----
|
|
Color
Plates |
|
|
| |
|
Plate
1: Trichomonads |
|
-----
|
| |
|
Plate2
: Clue cells of G. vaginalis |
|
-----
|
| |
|
Plate
3: Candida |
|
-----
|
| |
|
Plate
4: Vaginal candidiasis |
|
-----
|
| |
|
Plate
5: Severe vulvar intraepithelial neoplasia (VIN3) |
|
-----
|
| |
|
Plate
6: Nontender chancres (kissing lesions) |
|
-----
|
| |
|
Plate
7: Extensive vulvar condylomata acuminata |
|
-----
|
| |
|
Plate
8: Cervical intraepithelial neoplasia (CIN3) |
|
-----
|
| |
|
Plate
9: Mucopurulent cervicitis |
|
-----
|
| |
|
Plate
10: Profuse purulent frothy vaginal discharge |
|
-----
|
| |
|
Plate
11: Pelvic inflammatory disease |
|
-----
|
| |
|
Plate
12: Chancroid |
|
-----
|
| |
|
Plate
13: Condyloma latum in secondary syphilis |
|
-----
|
| |
|
Plate
14: Lesion of herpes simplex |
|
-----
|
| |
|
Plate
15: Herpes simplex in woman with AIDS |
|
-----
|
| |
|
Plate
16: Apthous genital ulceration |
|
-----
|
| |
|
Plate
17: Apthous oral ulceration |
|
-----
|
| VII. |
HIV
And Reproduction |
|
|
| |
|
Introduction |
|
-----
|
| |
|
Counseling |
|
-----
|
| |
|
Contraception |
|
-----
|
| |
|
Pregnancy
Testing |
|
-----
|
| |
|
HIV
and Fertility |
|
-----
|
| |
|
Effects
of Pregnancy and HIV Infection |
|
-----
|
| |
|
Effect
of HIV on Pregnancy Course and Outcome |
|
-----
|
| |
|
Perinatal
Transmission |
|
-----
|
| |
|
Guidelines
for Care |
|
-----
|
| |
|
Intrapartum |
|
-----
|
| |
|
Postpartum |
|
-----
|
| |
|
Care
of the HIV-Exposed Infant |
|
-----
|
| |
|
References |
|
-----
|
VIII.
|
Addressing
Cultural Issues To Improve Quality of Care |
|
|
| |
|
Introduction |
|
-----
|
| |
|
Economic
Issues |
|
-----
|
| |
|
Gender
Roles and Social Expectations |
|
-----
|
| |
|
Psychological
Issues |
|
-----
|
| |
|
Provider-Patient
Communication |
|
-----
|
| |
|
Cultural
Issues |
|
-----
|
| |
|
Interventions
|
|
-----
|
| |
|
Summary |
|
-----
|
| |
|
References |
|
-----
|
| IX. |
Psychiatric
Issues |
|
|
| |
|
Introduction |
|
-----
|
| |
|
Perspectives
On Being A Woman With HIV |
|
-----
|
| |
|
Need
For Multiservice Clinical Programs |
|
-----
|
| |
|
Psychiatric
Disorders |
|
-----
|
| |
|
Diagnosis
Of Major Depressive Disorder |
|
-----
|
| |
|
Psychopharmacology
For The HIV-Positive Woman: General Guidelines |
|
-----
|
| |
|
Evaluation
Of Suicide Risk |
|
-----
|
| |
|
Care
Provider Issues |
|
-----
|
| |
|
References |
|
-----
|
| X. |
Substance
Abuse |
|
|
| |
|
Substance
Use And Abuse |
|
-----
|
| |
|
Epidemiology
Of Substance Abuse |
|
-----
|
| |
|
Substance
Abuse And HIV |
|
-----
|
| |
|
Comorbidity
Related To Substance Abuse |
|
-----
|
| |
|
Substance
Abuse In Women |
|
-----
|
| |
|
Impact
Of Societal Perceptions And Beliefs |
|
-----
|
| |
|
Identification
Of Substance Use/Abuse |
|
-----
|
| |
|
Treatment
Readiness And Harm Reduction |
|
-----
|
| |
|
Treatment
Of Substance Abuse |
|
-----
|
| |
|
Predictors
Of Drug Treatment Retention And The Durability Of Treatment
Gains |
|
-----
|
| |
|
Relapse |
|
-----
|
| |
|
Substance
Abuse In Pregnancy |
|
-----
|
| |
|
Antiretroviral
Therapy In Substance Abusers |
|
-----
|
| |
|
Criminal
Justice Settings |
|
-----
|
| |
|
Conclusion |
|
-----
|
| |
|
References |
|
-----
|
| XI. |
Adolescents
|
|
|
| |
|
Epidemiology |
|
-----
|
| |
|
HIV
Care For Adoloscents |
|
-----
|
| |
|
Summary |
|
-----
|
| |
|
References |
|
-----
|
| XII. |
Palliative
And End-Of-Life Care |
|
|
| |
|
Introduction |
|
-----
|
| |
|
Quality
Of Life |
|
-----
|
| |
|
Symptoms
Throughout Disease |
|
-----
|
| |
|
Prognosis |
|
-----
|
| |
|
Telling
The Truth And Breaking Bad News |
|
-----
|
| |
|
Realistic
Goal Setting and Advance Care Planning |
|
-----
|
| |
|
End-Of-Life
Issues |
|
-----
|
| |
|
Care
Of The Care Provider |
|
-----
|
| |
|
References |
|
-----
|
| XIII. |
Occupational
Exposure |
|
|
| |
|
Introduction |
|
-----
|
| |
|
Magnitude
Of Risk |
|
-----
|
| |
|
Risk
Factors For Occupational HIV Transmission |
|
-----
|
| |
|
Preventing
Occupational Exposure |
|
-----
|
| |
|
HIV
Infection Following Occupational Exposure |
|
-----
|
| |
|
Postexposure
Management |
|
-----
|
| |
|
Special
Considerations |
|
-----
|
| |
|
The
HIV-Seropositive HCW |
|
-----
|
| |
|
References |
|
-----
|
XIV.
|
Pharmacologic
Considerations in HIV-infected Pregnant Patients |
|
|
| |
|
List
Of Tables |
|
-----
|
| |
|
Introduction |
|
-----
|
| |
|
Pharmacokinetics
Of Drugs In Pregnancy |
|
-----
|
| |
|
References |
|
-----
|
| XV. |
Resources |
|
|
| |
|
How
To Use This Chapter |
|
-----
|
| |
|
Resources
With Topic Areas |
|
-----
|
| XVI. |
International
Issues |
|
|
| |
|
Introduction |
|
-----
|
| |
|
India |
|
-----
|
| |
|
Zambia |
|
-----
|
| |
|
Brazil |
|
-----
|
| |
|
References |
|
-----
|
| XVII. |
Nutrition
Counseling, Care and Support |
|
|
| |
|
Introduction |
|
-----
|
| |
|
Background |
|
-----
|
| |
|
General
Principles |
|
-----
|
| |
|
Recommendations |
|
-----
|
| |
|
References |
|
-----
|
|
Indexes |
|
|
| |
|
Topic
Index |
|
-----
|
| |
|
Drug
Index |
|
-----
|
